Vimarsana
Biggest News Aggregation in the World

Electronic Common Technical Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Electronic Common Technical Document. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Electronic Common Technical Document Today - Breaking & Trending Today

New Drug Application (NDA) Submissions 505(b)(1) Or 505(b)(2) - Vimarsana News

New Drug Application (NDA) Submissions 505(b)(1) Or 505(b)(2)

There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough...

Uncovering the Hidden Insights in Clinical Trial Documents: Critical Steps to Intelligent Document Processing - Vimarsana News

Uncovering the Hidden Insights in Clinical Trial Documents: Critical Steps to Intelligent Document Processing

In clinical trials, pharmaceutical companies are seeking to optimize operations and improve efficiency by automating and enhancing processes through Artificial Intelligence (AI) and Machine Learning (ML). One area where this can reap tangible benefits across clinical trials is in data processing. A typical clinical trial generates over 13,000 documents in various formats (text, voice, video, apps, and web entries), making data gathering, organization and analysis challenging. It’s here that implementing automated Intelligent Document Processing (IDP) can significantly benefit clinical t...

LEXISNEXIS® REED TECH AND ONIX LIFE SCIENCES EXPAND STRATEGIC ALLIANCE TO GUIDE PHARMA CUSTOMERS TO MARKET FASTER - Vimarsana News

LEXISNEXIS® REED TECH AND ONIX LIFE SCIENCES EXPAND STRATEGIC ALLIANCE TO GUIDE PHARMA CUSTOMERS TO MARKET FASTER

/PRNewswire/ -- Professionals in the life sciences industry rely on unique regulatory affairs expertise to effectively manage the full end-to-end Electronic...

Tips To Follow And Mistakes To Avoid In The FDA Investigational New Drug Process - Food and Drugs Law - Vimarsana News

Tips To Follow And Mistakes To Avoid In The FDA Investigational New Drug Process - Food and Drugs Law

The Investigational New Drug Application or IND is a key step in this journey.

Source: mondaq.com
OKYO Pharma LTD: OKYO Pharma Limited - Final audited results for the year ended 31 March 2022 - Vimarsana News

OKYO Pharma LTD: OKYO Pharma Limited - Final audited results for the year ended 31 March 2022

LONDON and NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO) (the "Company") is pleased to announce its final audited results for the year ended 31 March 2022. Summary of OKYO-101 studies during the last year OK-101